MAPK3 and cancer: In solid cancer tissues, the HSPB1/p38 MAPK and HSPB1/ERK1/2 (p42/p44 MAPKs) pathways were activated, and activation of the HSPB1/MAPKs conferred tumour cells with resistance to ferroptosis and contributed to cancer progression.31, 32